Composite CA15-3, LDH, and Albumin Index as a Predictor of Survival in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine

<b>Background/Objectives</b>: Trastuzumab emtansine (T-DM1) is widely used in Human Epidermal Growth Factor Receptor2 (HER2)-positive metastatic breast cancer; however, outcomes vary, and reliable prognostic markers remain limited. We developed the CALA index as a composite biomarker integrating CA1...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Nagihan Kolkıran, Atike Pınar Erdoğan, Mustafa Şahbazlar, Müge Kurul Yeniay, Sinan Ünal, Mehmet Sinan Akarca, Elif Atağ Akyürek, Özge Demirkıran, Bilgin Demir, Ferhat Ekinci
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2026-05-01
Sarja:	Pharmaceuticals
Aiheet:	breast cancer trastuzumab emtansine prognostic index overall survival
Linkit:	https://www.mdpi.com/1424-8247/19/6/809
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!